MedPath

Education for Prevention of Melanoma in Hispanic Populations

Phase 2
Active, not recruiting
Conditions
Melanoma
Interventions
Other: Educational Intervention
Other: Questionnaire Administration
Registration Number
NCT05388851
Lead Sponsor
Mayo Clinic
Brief Summary

This clinical trial is to develop an educational platform to educate and prevent melanoma in Hispanic populations. Melanoma is cancer arising in the skin. Educational platforms to increase the knowledge and practice of sun smart behaviors (sunscreen use, sun protective clothing use, self-skin examination) may help reduce risk of and incidence of melanoma and improve cancer survival.

Detailed Description

PRIMARY OBJECTIVES:

I. Develop online education platform to educate the Hispanic community. II. Demonstrate improvement in knowledge and practice of sun smart behaviors. III. Determine if the education platform leads to increase visits to their medical provider and increase diagnosis of skin cancers, particularly melanoma, in our population.

OUTLINE:

Participants complete an educational training module and complete questionnaire at baseline (before educational training module) and 3 months after completing educational training.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
145
Inclusion Criteria
  • Mayo Clinic patients who self-identify as Hispanic or Latino
  • Age 18 and older
  • Have an email on file with Mayo Clinic
Read More
Exclusion Criteria
  • All patients who do not meet inclusion criteria
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Prevention (Educational training)Educational InterventionParticipants complete an educational training module and complete questionnaire at baseline (before educational training module) and 3 months after completing educational training.
Prevention (Educational training)Questionnaire AdministrationParticipants complete an educational training module and complete questionnaire at baseline (before educational training module) and 3 months after completing educational training.
Primary Outcome Measures
NameTimeMethod
Knowledge score after completing the educational moduleUp to 3 months

For quantitative variables, descriptive statistics including number of observations, mean, median, standard deviation, and range will be given for the values. Qualitative variables will be summarized using counts and percentages. Associations between quantitative variables will be conducted using the Pearson linear correlation coefficient, and the Chi-squared or Fisher's exact test for categorical variables.The melanoma knowledge score will be a percent correct, between 0% and 100% (100% is the best score), on a participant questionnaire. The primary outcome is the change in participant melanoma knowledge score before and immediately after completing the melanoma education (the intervention in this study).

Secondary Outcome Measures
NameTimeMethod
Knowledge score three months after completing the educational module3 months after completing education module

For quantitative variables, descriptive statistics including number of observations, mean, median, standard deviation, and range will be given for the values. Qualitative variables will be summarized using counts and percentages. Associations between quantitative variables will be conducted using the Pearson linear correlation coefficient, and the Chi-squared or Fisher's exact test for categorical variables.The secondary outcome is their melanoma knowledge score at the three-month follow-up.

Trial Locations

Locations (1)

Mayo Clinic in Arizona

🇺🇸

Scottsdale, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath